Escitalopram Oxalate
Who holds supplier records for Escitalopram Oxalate? 26 organisations hold a current record for Escitalopram Oxalate: an active US FDA Type II Drug Master File or a CEP. A further 6 organisations have only historical (inactive) DMF filings. 18 of them hold a valid EU Certificate of Suitability. Recorded organisation countries for current records: India (20), China (2) and Italy (1); not recorded for 3.
Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records
Cite as: PharmaTek, “Escitalopram Oxalate: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/escitalopram-oxalate
Reading the evidence
- 26 current records
Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.
- Most recorded organisations are in India
20 of the 23 current records with a recorded country list India. Organisation country is not necessarily the manufacturing site.
- 12 with a company-level GMP certificate on record
These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.
Current records (26)
Organisations holding an active US FDA Type II Drug Master File or a CEP for Escitalopram Oxalate. Country is the organisation's recorded country, not necessarily the manufacturing site.
- Cipla LimitedIndiaCEP Company GMP cert on recordActive DMF 16636, 38976 · latest filing Oct 2023
- Hetero Labs LimitedIndiaCEP Company GMP cert on recordActive DMF 17960, 26185 · latest filing Jun 2012
- JUBILANT BIOSYS LTDIndiaCEPActive DMF 19446, 22864 · latest filing Aug 2009
- APITORIA PHARMA PRIVATE LTDIndiaCEP Company GMP cert on recordActive DMF 19088 · latest filing Dec 2005
- Dr. Reddy's Laboratories Ltd.IndiaCEP Company GMP cert on recordActive DMF 18342, 25873 · latest filing Mar 2012
- Maithri Laboratories Private LimitedIndiaCEP Company GMP cert on recordActive DMF 41315 · latest filing Mar 2025
- MATRIX PHARMACORP PRIVATE LTDIndiaCEPActive DMF 18213 · latest filing Mar 2005
- MICRO LABS LTDIndiaCEP Company GMP cert on recordActive DMF 34568, 24684 · latest filing Nov 2020
- Neuland Laboratories LimitedIndiaCEPActive DMF 19662 · latest filing Aug 2006
- RUYUAN HEC PHARM CO LTDCEPActive DMF 35183 · latest filing Sept 2020
- SHODHANA LABORATORIES LTDIndiaCEPActive DMF 39200 · latest filing Dec 2023
- SMS Pharmaceuticals limitedIndiaCEP Company GMP cert on recordActive DMF 40721 · latest filing Nov 2024
- SYNERGENE ACTIVE INGREDIENTS PVT LTDIndiaCEPActive DMF 41048 · latest filing May 2025
- VIRUPAKSHA ORGANICS LTDIndiaCEPActive DMF 36632 · latest filing Jan 2022
- Zhejiang Huahai Pharmaceutical Co., Ltd.ChinaCEP Company GMP cert on recordActive DMF 20081 · latest filing Oct 2006
- ARCH PHARMALABS LTDIndiaActive DMF 19663 · latest filing Jun 2006
- Cadila Pharmaceuticals LimitedIndia Company GMP cert on recordActive DMF 22440 · latest filing Jan 2009
- H LUNDBECK ASActive DMF 14103 · latest filing Apr 1999
- Macleods Pharmaceuticals Ltd.India Company GMP cert on recordActive DMF 22900 · latest filing Jun 2009
- RAKS PHARMA PVT LTDIndiaActive DMF 26967 · latest filing Mar 2013
- WUXI JIDA PHARMACEUTICAL CO LTDActive DMF 25519 · latest filing Nov 2011
- Zhejiang Haisen Pharmaceutical Co., Ltd.ChinaActive DMF 40923 · latest filing Jan 2025
- Zydus Lifesciences LimitedIndia Company GMP cert on recordActive DMF 18119 · latest filing Feb 2005
- ItalyCEP Company GMP cert on record
- IndiaCEP
- VENKAR CHEMICALS PRIVATE LIMITEDIndiaCEP
The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.
Valid CEP holder entries (18)
Certificates of Suitability on the EDQM register for Escitalopram Oxalate, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer. 28 certificates in total, including withdrawn, expired, suspended and repeat certificates.
| Holder | Country | Certificate | Issued | EU GMP at holder's address |
|---|---|---|---|---|
| SHODHANA LABORATORIES PRIVATE LIMITED Medchal Malkajgiri | IN | CEP 2018-278 - Rev 02 Escitalopram oxalate | Oct 2026 | — |
| MAITHRI LABORATORIES PRIVATE LIMITED Gaddapotharam Village | IN | CEP 2025-247 - Rev 00 Escitalopram oxalate, Milled and non-milled | Oct 2026 | — |
| SYNERGENE ACTIVE INGREDIENTS PRIVATE LIMITED Hyderabad | IN | CEP 2025-192 - Rev 00 Escitalopram oxalate | Aug 2026 | — |
| RUYUAN HEC PHARM CO., LTD. Shaoguan | CN | CEP 2020-258 - Rev 01 Escitalopram oxalate | Aug 2026 | — |
| NEULAND LABORATORIES LIMITED Hyderabad | IN | CEP 2021-161 - Rev 04 Escitalopram oxalate, Process-III | Aug 2026 | — |
| SMS PHARMACEUTICALS LIMITED Hyderabad | IN | CEP 2025-082 - Rev 00 Escitalopram oxalate | May 2026 | — |
| ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD. Taizhou | CN | CEP 2016-178 - Rev 02 Escitalopram oxalate, Micronised, milled and non-micronised | Jan 2026 | Inspected May 2026 Italy |
| JUBILANT BIOSYS LIMITED Nanjangud | IN | CEP 2017-082 - Rev 01 Escitalopram oxalate | Oct 2025 | — |
| MATRIX PHARMACORP PRIVATE LIMITED Sangareddy District | IN | CEP 2019-130 - Rev 04 Escitalopram oxalate, Process II | Sept 2025 | — |
| MICRO LABS LIMITED Bengaluru | IN | CEP 2016-250 - Rev 02 Escitalopram oxalate | May 2025 | — |
| HETERO LABS LIMITED Hyderabad | IN | CEP 2016-306 - Rev 01 Escitalopram oxalate, Process I | May 2025 | — |
| SMILAX LABORATORIES LIMITED Hyderabad | IN | CEP 2023-012 - Rev 00 Escitalopram oxalate | Oct 2024 | — |
| OLON S.P.A. Rodano | IT | CEP 2018-126 - Rev 02 Escitalopram oxalate | Aug 2024 | Inspected Mar 2025 Italy |
| APITORIA PHARMA PRIVATE LIMITED Hyderabad | IN | CEP 2021-321 - Rev 02 Escitalopram oxalate, Process II | Jul 2024 | — |
| VENKAR CHEMICALS PVT. LTD. Hyderabad | IN | CEP 2022-163 - Rev 00 Escitalopram oxalate | Jun 2024 | — |
| CIPLA LIMITED Mumbai | IN | CEP 2023-413 - Rev 00 Escitalopram oxalate, Process-II | May 2024 | — |
| VIRUPAKSHA ORGANICS LIMITED Hyderabad | IN | CEP 2022-032 - Rev 00 Escitalopram oxalate | May 2024 | — |
| DR. REDDY'S LABORATORIES LIMITED Hyderabad | IN | R0-CEP 2019-222 - Rev 01 Escitalopram oxalate | Jun 2023 | — |
The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.
Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.
Historical records (6)
Organisations whose Type II DMFs for Escitalopram Oxalate are no longer active. These show a past filing, not current supply.
Show all 6 historical records
- TOKUYAMA CORPInactive DMF 31807 · filed Jul 2017
- India · Inactive DMF 25660 · filed Mar 2012
- India · Inactive DMF 23234 · filed Oct 2009
- India · Inactive DMF 22757 · filed May 2009
- India · Inactive DMF 19251 · filed Mar 2006
- India · Inactive DMF 19105 · filed Dec 2005
US product patents and exclusivity
The FDA Orange Book lists patents and exclusivities for specific approved products (30 listed products contain Escitalopram Oxalate). The latest listed exclusivity ended 16 Sept 2026. These dates are product-specific: they can cover a formulation, a combination or a method of use, and do not on their own show whether the ingredient is protected or whether generics are already approved. Check the individual product entries before planning a launch.
Other forms of this substance
A DMF or CEP is listed under the form it names. Salts, esters and hydrates of the same active substance have their own records:
Overview
Escitalopram Oxalate is an antidepressant belonging to the selective serotonin reuptake inhibitor (SSRI) class. It is primarily used to treat major depressive disorder and generalized anxiety disorder.
Chemical identity
- IUPAC name
- 1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-3H-2-benzofuran-5-carbonitrile
- Canonical SMILES
- CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F
- InChIKey
- WSEQXVZVJXJVFP-UHFFFAOYSA-N
- Synonyms
- Lexapro API, citalopram, Nitalapram, Cipram, Citalopramum, Citadur, Lu 10-171, CHEBI:77397, Cytalopram, RefChem:5691, CHEBI:3723, N06AB04
Pharmacologic class
As the US FDA states it for this active substance on product listings.
- Established pharmacologic class
- Serotonin Reuptake Inhibitor
- Mechanism of action
- Serotonin Uptake Inhibitors
Therapeutic areas
Record history
No change to the current records between 13 Nov 2026 and 16 Nov 2026.
Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week
What these records establish
- An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
- A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
- Historical records show a past filing, not current supply.
- Company GMP certificates are matched to the organisation, not to the site making this substance.
- A substance missing from these registers is not evidence that no supplier exists.
Frequently asked questions
Which organisations hold current supplier records for Escitalopram Oxalate?
26 organisations hold an active US FDA Type II Drug Master File or a CEP for Escitalopram Oxalate: Cipla Limited (India), Hetero Labs Limited (India), JUBILANT BIOSYS LTD (India), APITORIA PHARMA PRIVATE LTD (India), Dr. Reddy's Laboratories Ltd. (India), Maithri Laboratories Private Limited (India), MATRIX PHARMACORP PRIVATE LTD (India) and MICRO LABS LTD (India), and 18 more listed on this page. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.
Which Escitalopram Oxalate Drug Master Files are active?
Cipla Limited (DMF 16636, 38976), Hetero Labs Limited (DMF 17960, 26185), JUBILANT BIOSYS LTD (DMF 19446, 22864), APITORIA PHARMA PRIVATE LTD (DMF 19088), Dr. Reddy's Laboratories Ltd. (DMF 18342, 25873), Maithri Laboratories Private Limited (DMF 41315), MATRIX PHARMACORP PRIVATE LTD (DMF 18213) and MICRO LABS LTD (DMF 34568, 24684) and 15 more. The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.
What do the historical Escitalopram Oxalate records mean?
6 organisations have only inactive Type II DMFs for Escitalopram Oxalate. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.
Does Escitalopram Oxalate have a European Certificate of Suitability?
Yes. 18 organisations hold a valid CEP for Escitalopram Oxalate on the EDQM register, including SHODHANA LABORATORIES PRIVATE LIMITED Medchal Malkajgiri (IN), MAITHRI LABORATORIES PRIVATE LIMITED Gaddapotharam Village (IN), SYNERGENE ACTIVE INGREDIENTS PRIVATE LIMITED Hyderabad (IN), RUYUAN HEC PHARM CO., LTD. Shaoguan (CN), NEULAND LABORATORIES LIMITED Hyderabad (IN) and SMS PHARMACEUTICALS LIMITED Hyderabad (IN) and 12 more. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.
How do I qualify a Escitalopram Oxalate supplier?
Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.
Do you supply Escitalopram Oxalate?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.